First-line, early and long-term eculizumab therapy in atypical hemolytic uremic syndrome: a case series in pediatric patients

S Yüksel, H Evrengül, ZB Özçakar, T Becerir, N Yalçın… - Pediatric Drugs, 2016 - Springer
Introduction Studies relating to first-line, early, and long-term eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients

S Yüksel, H Evrengül, ZB Özçakar… - Paediatric …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction Studies relating to first-line, early, and long-term eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients.

S Yüksel, H Evrengül, ZB Özçakar, T Becerir… - Paediatric …, 2016 - europepmc.org
Materials and methods We reviewed the data from four pediatric patients with aHUS who
were treated with eculizumab. In three of them, eculizumab was used as a first-line therapy …

First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients

S Yüksel, H Evrengül, ZB Özçakar, T Becerir… - Pediatric …, 2016 - search.proquest.com
Introduction Studies relating to first-line, early, and longterm eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

[PDF][PDF] First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients

S Yüksel, H Evrengül, ZB Ozçakar, T Becerir, N Yalçın… - academia.edu
Introduction Studies relating to first-line, early, and longterm eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

First-line, early and long-term eculizumab therapy in atypical hemolytic uremic syndrome: a case series in pediatric patients

S Yüksel, H Evrengül, ZB Özçakar, T Becerir… - Pediatric …, 2016 - gcris.pau.edu.tr
Introduction: Studies relating to first-line, early, and long-term eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

[PDF][PDF] First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients

S Yüksel, H Evrengül, ZB Ozçakar, T Becerir, N Yalçın… - fatihozaltin.com
Introduction Studies relating to first-line, early, and longterm eculizumab treatment and
outcomes in children with atypical hemolytic uremic syndrome (aHUS) are scarce and …

First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients

S YÜKSEL, H Evrengul, Z ÖZÇAKAR… - PEDIATRIC …, 2016 - avesis.hacettepe.edu.tr
Studies relating to first-line, early, and long-term eculizumab treatment and outcomes in
children with atypical hemolytic uremic syndrome (aHUS) are scarce and unclear. The aim …